Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 426 - 450 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010020
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/14:0)
126457388 970.563008 C47H87O18P
Diacylglycerophosphoinositolglycans LMGP15010021
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:0)
126457389 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010022
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:1(9Z))
126457390 996.578658 C49H89O18P
Diacylglycerophosphoinositolglycans LMGP15010023
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:2(9Z,12Z))
126457391 994.563008 C49H87O18P
Diacylglycerophosphoinositolglycans LMGP15010024
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/18:0)
126457392 1026.625608 C51H95O18P
Diacylglycerophosphoinositolglycans LMGP15010025
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/18:1(9Z))
126457393 1024.609958 C51H93O18P
Diacylglycerophosphoinositolglycans LMGP15010026
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/14:0)
126457394 968.547358 C47H85O18P
Diacylglycerophosphoinositolglycans LMGP15010027
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/16:0)
126457395 996.578658 C49H89O18P
Diacylglycerophosphoinositolglycans LMGP15010028
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/16:1(9Z))
126457396 994.563008 C49H87O18P
Diacylglycerophosphoinositolglycans LMGP15010029
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/16:2(9Z,12Z))
126457397 992.547358 C49H85O18P
Diacylglycerophosphoinositolglycans LMGP15010030
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/18:0)
126457398 1024.609958 C51H93O18P
Diacylglycerophosphoinositolglycans LMGP15010031
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/18:1(9Z))
126457399 1022.594308 C51H91O18P
Diacylglycerophosphoinositolglycans LMGP15010032
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/14:0)
126457400 986.594308 C48H91O18P
Diacylglycerophosphoinositolglycans LMGP15010033
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:0)
126457401 1014.625608 C50H95O18P
Diacylglycerophosphoinositolglycans LMGP15010034
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:1(9Z))
126457402 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010035
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:2(9Z,12Z))
126457403 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010036
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/18:0)
126457404 1042.656908 C52H99O18P
Diacylglycerophosphoinositolglycans LMGP15010037
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/18:1(9Z))
126457405 1040.641258 C52H97O18P
Diacylglycerophosphoinositolglycans LMGP15010038
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/14:0)
126457406 984.578658 C48H89O18P
Diacylglycerophosphoinositolglycans LMGP15010039
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:0)
126457407 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010040
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:1(9Z))
126457408 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010041
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:2(9Z,12Z))
126457409 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010042
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/18:0)
126457410 1040.641258 C52H97O18P
Diacylglycerophosphoinositolglycans LMGP15010043
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/18:1(9Z))
126457411 1038.625608 C52H95O18P
Diacylglycerophosphoinositolglycans LMGP15010044
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/14:0)
126457412 982.563008 C48H87O18P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024